Austar Lifesciences Balance Sheet Health
Financial Health criteria checks 3/6
Austar Lifesciences has a total shareholder equity of CN¥780.6M and total debt of CN¥386.3M, which brings its debt-to-equity ratio to 49.5%. Its total assets and total liabilities are CN¥2.1B and CN¥1.4B respectively.
Key information
49.5%
Debt to equity ratio
CN¥386.27m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥139.98m |
| Equity | CN¥780.63m |
| Total liabilities | CN¥1.36b |
| Total assets | CN¥2.14b |
Recent financial health updates
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 16Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23Financial Position Analysis
Short Term Liabilities: 6118's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 6118's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥168.6M).
Debt to Equity History and Analysis
Debt Level: 6118's net debt to equity ratio (31.5%) is considered satisfactory.
Reducing Debt: 6118's debt to equity ratio has increased from 4.1% to 49.5% over the past 5 years.
Debt Coverage: 6118's debt is not well covered by operating cash flow (5.6%).
Interest Coverage: Insufficient data to determine if 6118's interest payments on its debt are well covered by EBIT.